<DOC>
	<DOCNO>NCT00197054</DOCNO>
	<brief_summary>The candidate malaria vaccine RTS , S/AS02A develop GSK Biologicals demonstrate 30 % efficacy clinical episode malaria approximately 58 % efficacy severe malaria disease . As potential improvement RTS , S/AS02A , another candidate vaccine RTS , S/AS01B develop parallel collaboration Walter Reed Army Institute Research ( WRAIR ) . This study first administration RTS , S/AS01B vaccine African adult establish safety immunogenicity population . Preliminary indication vaccine efficacy adjuvant establish monitoring time first infection Plasmodium falciparum .</brief_summary>
	<brief_title>A Study Evaluate Safety , Immunogenicity Proof-of-concept RTS , S/AS02A , RTS , S/AS01B , Two Candidate Malaria Vaccines Malaria-experienced Adults Living Western Kenya .</brief_title>
	<detailed_description>The study comprise 3 group participate subject randomly allocate one three group . The first group receive RTS , S/AS01B , second group receive RTS , S/AS02A third group receive rabies vaccine . Immunization give IM injection 0 , 1 , 2 month schedule . Infants follow daily 7 day solicit symptoms 30 day unsolicited symptom vaccine dose . Serious adverse event record throughout study period . A week prior Dose 3 , subject treat licenced anti-malarial drug . Starting two week Dose 3 , subject monitor 14-week duration detection malaria infection .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<criteria>Inclusion criterion : Healthy male female volunteer age 18 35 year time first vaccination give write consent participation study include If volunteer female , must nonchildbearing potential , i.e . either surgically sterilize one year postmenopausal ; , childbearing potential , must abstinent use adequate contraceptive precaution 30 day prior vaccination , negative pregnancy test must agree continue precaution two month completion vaccination series Exclusion criterion : If subject plan take vaccine foreseen study protocol within 30 day first dose vaccine ( ) exception tetanus toxoid exclude Volunteers confirm suspected immunosuppressive immunodeficient condition Family history congenital hereditary immunodeficiency History allergic reaction previous immunization HBsAg positive subject History splenectomy Pregnant lactating female exclude study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>